Laurent Arnould

1 Professeur Marion Street
Dijon, 21000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 85 publications

Age-related distribution of homologous recombination deficiency in advanced ovarian carcinoma: a large real-world French cohort.

Age-related distribution of homologous recombination deficiency in advanced ovarian carcinoma: a large real-world French cohort.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: March 26, 2026

Automated Radiomics Analysis from Multi-Modal Image Segmentation for Predicting Triple Negative Breast Cancer.

Automated Radiomics Analysis from Multi-Modal Image Segmentation for Predicting Triple Negative Breast Cancer.

Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Published: December 03, 2025

Deep Learning-Driven Radiomic Feature Extraction for Predicting Complete Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer from 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scans.

Deep Learning-Driven Radiomic Feature Extraction for Predicting Complete Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer from 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scans.

Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Published: December 03, 2025

Mirvetuximab soravtansine-associated microcystic keratopathy

Mirvetuximab soravtansine-associated microcystic keratopathy

Journal: Journal francais d'ophtalmologie

Published: August 03, 2025

Chemo-prAIdict Breast: A deep learning solution for predicting residual disease on biopsies of breast cancer patients treated with neoadjuvant chemotherapy.

Chemo-prAIdict Breast: A deep learning solution for predicting residual disease on biopsies of breast cancer patients treated with neoadjuvant chemotherapy.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 11, 2025

Automatic computation of breast cancer biomarkers from multiple [Formula: see text] F-FDG PET image segmentation.

Automatic computation of breast cancer biomarkers from multiple [Formula: see text] F-FDG PET image segmentation.

Journal: Scientific reports

Published: July 04, 2025

Dynamic DNA methylation changes during colorectal oncogenesis with insights from adenoma stages.

Dynamic DNA methylation changes during colorectal oncogenesis with insights from adenoma stages.

Journal: Scientific reports

Published: June 20, 2025

Challenges of a tailored immunohistochemistry algorithm for uterine leiomyosarcoma: an integrated analysis of leiomyomas with bizarre nuclei and fumarate hydratase (FH) deficiency.

Challenges of a tailored immunohistochemistry algorithm for uterine leiomyosarcoma: an integrated analysis of leiomyomas with bizarre nuclei and fumarate hydratase (FH) deficiency.

Journal: Histopathology

Published: November 04, 2024

Prevalence, clinicopathologic features and long-term overall survival of early breast cancer patients eligible for adjuvant abemaciclib and/or ribociclib.

Prevalence, clinicopathologic features and long-term overall survival of early breast cancer patients eligible for adjuvant abemaciclib and/or ribociclib.

Journal: NPJ breast cancer

Published: November 01, 2024

Case #2. Breast mucinous cystadenocarcinoma: A case report

Case #2. Breast mucinous cystadenocarcinoma: A case report

Journal: Annales de pathologie

Published: October 29, 2024

Deciphering human endogenous retrovirus expression in colorectal cancers: exploratory analysis regarding prognostic value in liver metastases.

Deciphering human endogenous retrovirus expression in colorectal cancers: exploratory analysis regarding prognostic value in liver metastases.

Journal: EBioMedicine

Published: August 09, 2024

Real-world prevalence, treatment and survival of "high risk" early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registry.

Real-world prevalence, treatment and survival of "high risk" early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registry.

Journal: Breast (Edinburgh, Scotland)

Published: July 02, 2024

Showing 1-12 of 85

Last Updated: 09/26/2026